Stada says starts due diligence in M&A process
FRANKFURT, Feb 25 German generic drugs maker Stada Arzneimittel said on Saturday it had started a structured bidding process after receiving takeover bids from three buyout groups.
* FTSEurofirst 300 up 0.1 pct in mid-session trading
* DAX slightly outperforms with 0.2 pct rise
* Healthcare stocks boosted by gains at Shire
* Traders see support for equities from M&A and ECB
By Sudip Kar-Gupta
LONDON, June 17 Gains in Germany's DAX equity index and new signs of corporate takeover activity propped up European stock markets on Tuesday, enabling them to claw back lost ground.
The pan-European FTSEurofirst 300 index, which had fallen in the last two sessions from 6-1/2 year highs, edged back up by 0.1 percent to 1,385.05 points.
The euro zone's blue-chip Euro STOXX 50 index also advanced by 0.1 percent to 3,264.76 points while the DAX - which hit a record high of 10,033.74 points on June 10 - rose 0.2 percent to 9,906.63 points.
German carmaker Daimler rose 0.2 percent to give one of the biggest lifts to both the DAX and the FTSEurofirst 300 indexes, after data on Tuesday showed a 4.3 percent rise in European car sales in May.
European healthcare stocks were boosted by a 2.7 percent gain in UK pharma group Shire. It was boosted after Reuters reported that Shire had hired investment bank Citi as an adviser, expecting to receive takeover approaches following a wave of deals in the healthcare sector.
A resurgence of corporate merger and acquisition (M&A) activity has lifted European stock markets this year, in spite of lingering signs of economic weakness in the euro zone.
"Whenever you see some M&A, you have to buy the stock market," said Toby Campbell-Gray, head of trading at Tavira Securities.
Over the last two sessions, European stock markets had retreated from multi-year highs as violence in Iraq pushed up the price of oil and knocked back airline and travel stocks.
However, many traders have said new economic stimulus measures from the European Central Bank should ensure that any pullback will be relatively short-lived, and the FTSEurofirst 300 remains up by 5 percent since the start of 2014.
"We may see a pullback for a couple of days, but in my view, it's nothing. This is a very strong bull market, and betting against it is a bad idea," said Andreas Clenow, hedge fund trader and principal at ACIES Asset Management.
Europe bourses in 2014: link.reuters.com/pap87v
Asset performance in 2014: link.reuters.com/gap87v
Today's European research round-up (Additional reporting by Alistair Smout; Editing by Susan Fenton)
CANNON BALL, N.D., Feb 25 Opponents of the Dakota Access Pipeline who were pushed out of their protest camp this week have vowed to keep up efforts to stop the multibillion-dollar project and take the fight to other pipelines as well.
Feb 24 Pfizer Inc said it received subpoenas from the U.S. Attorney's Office for the District of Massachusetts related to its support for organizations that provide financial help to Medicare patients.